PPT Slide

Ligand’s Pacesetting R&D Productivity

NCEs advanced to preclinical development stage

NCEs advanced to IND track or equivalent

NCEs advanced to clinical stage

$358 million research 24 NCEs (1)

(1) Compounds in active development